The Trump administration has made its stance clear on how it plans to handle Medicare drug negotiations under the Inflation Reduction Act. The administration announced Wednesday that it will consider “opportunities to bring greater transparency” to the process, aiming to release rules for drugs within the next 60 days. This move comes as part of a broader effort to ensure compliance with budgetary requirements while allowing stakeholders to provide feedback on how the process should work.
Source: https://endpts.com/trump-administration-makes-first-comments-on-how-it-will-run-ira-drug-negotiations